key: cord-0999029-tn6pmhvc
authors: Tang, Suzanne; Perez, Marina Sanchez; Saavedra-Campos, Maria; Paranthaman, Karthik; Myers, Richard; Fok, Jonathan; Crawley-Boevey, Emma; Dun-Campbell, Kate; Janarthanan, Roshni; Fernandez, Elena; Vusirikala, Amoolya; Patel, Bharat; Ma, Thomas; Amin-Chowdhury, Zahin; Shetty, Nandini; Zambon, Maria; Bell, Anita; Wynne-Evans, Edward; Chow, Yimmy; Ladhani, Shamez
title: Mass testing after a single suspected or confirmed case of COVID-19 in London care homes, April–May 2020: implications for policy and practice
date: 2021-02-23
journal: Age Ageing
DOI: 10.1093/ageing/afab054
sha: 7cf4002ac6066ca8aff9d90c0e60de09fae79e88
doc_id: 999029
cord_uid: tn6pmhvc

Introduction: Previous investigations have identified high rates of SARS-CoV-2 infection among residents and staff in care homes reporting an outbreak of COVID-19. We investigated care homes reporting a single suspected or confirmed case to assess whether early mass testing might reduce risk of transmission during the peak of the pandemic in London. Methods: Between 18–27 April 2020, residents and staff in care homes reporting a single case of COVID-19 to Public Health England had a nasal swab to test for SARS-CoV-2 infection by RT-PCR and subsequent whole genome sequencing. Residents and staff in two care homes were re-tested eight days later. Results: Four care homes were investigated. SARS-CoV-2 positivity was 20% (65/333) overall, ranging between 3–59%. Among residents, positivity ranged between 3–76% compared to 3–40% in staff. Half of the SARS-CoV-2 positive residents (23/46, 50%) and 63% of staff (12/19) reported symptoms within 14 days before or after testing. Repeat testing 8 days later in two care homes with the highest infection rates identified only two new cases. Genomic analysis demonstrated a small number of introductions of the virus into care homes, and distinct clusters within three of the care homes. Conclusions: We found extensive but variable rates of SARS-CoV-2 infection among residents and staff in care homes reporting a single case of COVID-19. While routine whole home testing has now been adopted into practice, care homes must remain vigilant and should be encouraged to report a single suspected case, which should trigger appropriate outbreak control measures.

Outbreaks of SARS-CoV-2 in care homes have devastating consequences for residents [1] [2] [3] [4] . Age, multimorbidity, disability, cognitive impairment and frailty make care home residents at higher risk of becoming infected with and dying from COVID-19 [5] [6] [7] . Non-specific and atypical presentations of COVID-19, especially in older adults with dementia and neurological conditions, can hinder early identification of cases [4, 5, [8] [9] [10] , leading to delays in isolation of positive cases and reinforcement of stringent infection prevention and control (IPC) measures, and potentially allowing for rapid and extensive spread of SARS-CoV-2 within the care homes.

In the UK, imported cases of SARS-CoV-2 were first detected in late January 2020 followed by sustained community circulation from early March, with London being one of the earliest and most affected cities [11] . Between 02 March and 01 May 2020, the UK Office for involved COVID- 19 [12] . With approximately 400,000 older people living in UK care homes [13] , 5,167 out of 15,514 (33%) nursing and residential homes in England had declared an outbreak by 01 May 2020, including 539 homes in London [14] .

Early in the first wave of the pandemic, little was known about the risk of infection and transmission of SARS-CoV-2 in care homes. Following the large number of outbreaks in care homes reported to Public Health England (PHE), enhanced outbreak investigations were initiated. In the first phase of the investigations conducted during 10-13 April 2020, we found that by the time an outbreakdefined as at least two suspected cases within 14 days was reported in a care home, almost half the residents and a fifth of staff had already been infected with SARS-CoV-2, most of whom were asymptomatic at the time of testing [15] . We therefore hypothesised that mass testing of residents and staff after a single case of SARS-CoV-2 in a care home might allow early identification and isolation of infected individuals and, together with rapid reinforcement of IPC measures, could potentially prevent further spread of the virus within the care home. Phase two of the London care home investigations, therefore, aimed to assess incidence, symptom status and transmission of SARS-CoV-2 through mass testing of staff and residents in care homes reporting a single suspected or confirmed case, with repeat testing one week later.

At the start of the COVID-19 pandemic in England, care homes were asked to report suspected or confirmed outbreaks (defined as 2 or more cases) to Public Health England Table S1 ).

Two rounds of mass testing were undertaken in the recruited care homes. Nasal swabs were taken from all residents and staff working in the care homes at the time of the first round of testing (day 0). The residents and staff were re-tested on day 8 to detect any further transmission of the virus within the care home. In two of the care homes, due to practical considerations, it was not possible to re-test residents on day 8 so only staff were re-tested.

Staff members who tested positive for SARS-CoV-2 were re-swabbed every week until a negative result was obtained. Following verbal consent from the resident or next-of-kin as appropriate, nasal swabs for residents were taken by trained care staff who received an internal control [17] .

Individuals were classified as symptomatic if they reported typical (fever >37. 

Four care homes were recruited for this investigation. Care home D was a mixed residential and nursing home and the other three were residential homes (Table 1) . IPC measures in all care homes included enhanced cleaning, closing to visitors, isolating residents in single rooms where possible, and restricting use of shared spaces, although these were implemented at different times. Care homes A and D were closed to visitors, restricted shared spaces and isolated residents by the end of March 2020. In contrast, care homes B and C did not implement isolation and restriction of shared spaces until after mid-April. 

Testing took place within two days of a care home reporting a single suspected or confirmed case of SARS-CoV-2. Overall SARS-CoV-2 positivity was 20%, with higher positivity rates in care homes B (31%) and C (59%) compared to care homes A (11%) and D (3%) ( Table 2) .

Among residents, SARS-CoV-2 positivity ranged between 3-76% compared to 3-40% in (Table 2) .

Among 268 SARS-CoV-2 negative staff and residents, 10 (4%) reported having symptoms in the 14 days before or after testing, including 4 residents and 6 staff members (Table 3) . 

SARS-CoV-2 positivity among residents and staff decreased between the first and second rounds of sampling (Table 4 ). There were only two cases (one resident and one staff in different care homes) who initially tested negative on day 0 but subsequently tested positive on day 8 (Table 4 ). Of the 19 staff members who tested positive initially, two remained positive at day 8 but both tested negative one week later. (Table 3) .

Seven residents died; all were symptomatic and six were SARS-CoV-2 positive (6 of 23 symptomatic SARS-CoV-2 positive residents, 26%). Four deaths occurred in care home C and the other care homes reported one death each.

In total, 65 positive PCR samples from four care homes were submitted for WGS analysis. 

Unknown

information, however, was not available during the early pandemic. In the first phase of our care home investigations, we found high rates of SARS-CoV-2 infection among residents and staff in six London care homes reporting a possible outbreak with two or more confirmed or suspected cases of COVID-19 [15] . In that investigation, too, a high case fatality rate was observed among symptomatic SARS-CoV-2 positive residents, demonstrating the vulnerability of this group. Subsequent serological testing in the same London care homes found nearly all SARS-CoV-2 positive and two-thirds of SARS-CoV-2 negative staff and surviving residents had SARS-CoV-2 antibodies, highlighting the true extent of virus spread within these care homes [25] .

In order to try and identify outbreaks earlier, we immediately initiated phase two of the investigation to identify care homes reporting a single suspected or confirmed case of SARS-CoV-2. We hypothesised that this would allow early identification and isolation of infected individuals, which along with reinforcement of strict IPC measures, would prevent further transmission of the virus and protect the residents and staff. We found evidence for moderate transmission when mass screening was undertaken following a single case, although there was wide variation in the levels of infection detected among residents and staff across the four care homes under investigation. These differences are may be due to the care homes being at different stages of their outbreak at the time of initial testing. In care home C, for example, the outbreak continued to evolve, resulting in several hospitalisations and deaths in the two weeks after the initial swabbing. Other potential factors may be differences in resident profile, staff occupational risk factors such as working across different care homes [26] , or compliance with recommended IPC measures. Of note, care homes B and C, which had higher SARS-CoV-2 infection rates, began isolating residents and restricting the use of shared spaces in late April when directly advised by PHE. This was almost a month later than in care homes A and D, which were more proactive. The difference in control measures in the care homes could explain the findings of genomic analysis which identified significant clusters in care homes B and C, and suggests that following SARS-CoV-2 introduction into the care home, the virus was likely to have spread more extensively in these care homes with less stringent IPC measures in place. Very few staff members reported working across different care homes, although it is possible they may not have volunteered this information to the care home managers.

The identification of additional cases through mass testing in the first round emphasises the importance of maintaining high vigilance in such high-risk settings, given the variable clinical manifestations of SARS-CoV-2 especially in older residents with multiple comorbidities [8] [9] [10] . In particular, we found that although these care homes had reported only one suspected or confirmed case, upon further enquiry, a large proportion of residents and staff who tested

PCR positive reported having varying symptoms in the 14 days before the test. The reason for this is unclear, but it suggests that often COVID-19 infection may not be considered as a possibility when the presentations are mild or non-specific in both residents and staff, which further delays testing and means that staff may continue to work even if they have symptoms. Our findings also highlight the challenges posed by asymptomatic cases, which have been shown to play an important part in SARS-CoV-2 transmission, especially in institutional settings in care homes [4, 6, 15] . Our investigation found high rates of asymptomatic infection among both residents and staff, which varied by care home from 25% to 67%. The standard practice at the time was for care homes and other institutional settings to report outbreaks with at least 2 suspected or confirmed cases to PHE, which would initiate additional testing of symptomatic individuals only along with reinforcement of IPC measures. However, a high proportion of asymptomatic cases highlight the limitations of symptom-based surveillance and signals the need for mass testing of all staff and residents to identify and rapidly isolate infected residents and staff.

We conducted repeat testing one week after the initial sampling which identified very few additional SARS-CoV-2 infections, unlike our experience with the other London care home outbreaks, which lasted for many weeks and were associated with large numbers of hospitalisations or deaths [15] . It is likely that early reporting to PHE and the resultant early mass testing increased awareness and vigilance in the care homes and led to rapid identification and isolation of infected asymptomatic residents and staff who may otherwise have been missed. Moreover, the investigation team maintained daily contact with the care homes throughout the surveillance period to reinforce stringent IPC practices and provide outbreak management support.

In keeping with emerging reports of widespread asymptomatic SARS-CoV-2 infections in countries experiencing with high rates of SARS-CoV-2 [4, 6, [19] [20] [21] [22] , the findings of our first phase of investigations led to national recommendations for mass testing in care homes experiencing an outbreak. The phase two investigation reported here, however, provided additional unique information on the risk of infection and transmission in care homes reporting a single suspected or confirmed case, which had not been reported elsewhere.

This additional insight informed and supported public health authorities to update the UK care home testing strategy in May 2020 and provide whole home testing for all residents and staff as soon as they identified a single symptomatic case. As testing capacity increased, the UK government announced routine whole-home testing to be implemented weekly for all care home staff, and monthly for residents regardless of symptoms, in addition to mass testing in response to a suspected case or outbreak [27] .

There are some limitations to this investigation. Due to practical considerations, residents in care homes B and C were not tested during the second period of sampling. It is therefore not possible to determine with certainty that transmission was controlled after the initial testing although no additional cases or outbreaks were reported in these two care homes.

Additionally, testing was voluntary and not all the residents and staff were tested on both occasions, although the numbers that were not tested at both time points was low. It was also not possible to independently assess the level and rigour of IPC measures implemented by care homes and, therefore, it cannot be stated with certainty that these measures were directly responsible for limiting transmission and controlling the spread of infection. Symptom status for staff was self-reported, while resident symptoms were reported by their care staff, and both may be subject to potential recall or recording bias. A further limitation is that due to practical considerations, data on other contributing factors such as comorbidities and frailty were not routinely collected.

An important strength of this study, however, is the high uptake of testing among residents and staff across four care homes. The findings of this study highlight the limited value of symptom-based screening and further underscores the need for timely mass testing to confirm the extent of SARS-CoV-2 infections in care homes and other similar institutional settings.

Our findings indicate that, during periods of continuous community SARS-CoV-2 transmission, care homes are extremely vulnerable to large outbreaks. While routine whole home testing has now been adopted into practice across the country, with further roll out of rapid tests using lateral flow devices for staff, care homes must remain vigilant and should be encouraged to report a single case of suspected or confirmed SARS-CoV-2 in a resident, staff or visitor to public health authorities. This should trigger appropriate outbreak control measures, with rapid mass testing, isolation of infected individuals and reinforcement of robust IPC measures. 

COVID-19 in long-term care facilities: An upcoming threat that cannot be ignored

Surveillance of COVID-19 at long term care facilities in the EU/EEA

Wales see 20 000 excess deaths in care homes

SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes

Dementia care during COVID-19

Epidemiology of Covid-19 in a Long-Term Care Facility

The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study

Atypical presentations of COVID-19 in care home residents presenting to secondary care: A UK single centre study

COVID-19: Managing the COVID-19 pandemic in care homes for older people

Outbreak Investigation of COVID-19 Among Residents and Staff of an Independent and Assisted Living Community for Older Adults in

UK Office for National Statistics. 2020, Deaths involving COVID-19 in the care sector, England and Wales: deaths occurring up to 1 May 2020 and registered up to 9 May 2020 (provisional)

COVID-19: number of outbreaks in care homesmanagement information

Investigation of SARS-COV-2 in 6 care homes in London

Admission and Care of Patients in a Care Home during COVID-19

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Asymptomatic SARS-CoV-2 Infection in Nursing Homes

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility

High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities

Pattern of SARS-CoV-2 infection among dependant elderly residents living in long-term care facilities

Variation in SARS-CoV-2 Prevalence in U.S. Skilled Nursing Facilities

Facility-Wide Testing for SARS-CoV-2 in Nursing Homes -Seven

High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study

Increased risk of SARS-CoV-2 infection in staff working across different care homes: enhanced CoVID-19 outbreak investigations in London care Homes

Care Home COVID-19 Testing Guidance: For testing of staff and residents